Transcriptional control of hepatocanalicular transporter gene expression

Seminars in Liver Disease

Volumn 20, Issue 3, 2000, Pages 323-337

  Muller, M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

ABC transporter proteins; Bile secretion; Nuclear hormone receptors; Tumor necrosis factor

Indexed keywords

ABC TRANSPORTER; CARRIER PROTEIN; CELL NUCLEUS RECEPTOR; HORMONE RECEPTOR; MULTIDRUG RESISTANCE PROTEIN; NUCLEAR FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PREGNANE DERIVATIVE; PROTEIN P53; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR;

BILE SECRETION; BINDING SITE; CHOLESTEROL INTAKE; DNA DAMAGE; DNA SEQUENCE; GENE CASSETTE; GENE CONTROL; GENE EXPRESSION; HOMEOSTASIS; HUMAN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR BINDING; REVIEW; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; TRANSPORT KINETICS;

EID: 0033753489     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-9387     Document Type: Review

References (139)

1. Secretion of organic anions by hepatocytes: Involvement of homologues of the multidrug resistance protein
2. Molecular aspects of hepatobiliary transport
3. Hepatobiliary secretion of organic compounds: Molecular mechanisms of membrane transport
4. The secretory function of the liver: New insights in hepatobiliary transport
5. An inventory of the human ABC proteins
6. Steroid and nuclear receptors
7. The RXR heterodimers and orphan receptors
8. Nuclear orphan receptors: The search for novel ligands and signaling pathways
9. P450 gene induction by structurally diverse xenochemicals: Central role of nuclear receptors CAR, PXR, and PPAR
10. Orphan nuclear receptors: From gene to function
11. Bile acids: Natural ligands for an orphan nuclear receptor
12. Identification of a nuclear receptor for bile acids
13. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR
14. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors
15. Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR
16. Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta
17. Nuclear receptors: Coactivators, corepressors and chromatin remodeling in the control of transcription
18. SXR, a novel steroid and xenobiotic-sensing nuclear receptor
19. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway
20. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions
21. The pregnane X receptor: A promiscuous xenobiotic receptor that has diverged during evolution
22. The ATP-dependent glutathione S-conjugate export pump
23. A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements
24. The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene
25. The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene
26. Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene
27. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha
28. The LXRs: A new class of oxysterol receptors
29. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta
30. Nuclear receptor regulation of cholesterol and bile acid metabolism
31. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha
32. Peroxisome proliferator-activated receptors: Nuclear control of metabolism
33. Peroxisome proliferator-activated receptors: Three isotypes for a multitude of functions
34. Medical significance of peroxisome proliferator-activated receptors
35. The orphan nuclear hormone receptor LXR alpha interacts with the peroxisome proliferator-activated receptor and inhibits peroxisome proliferator signaling
36. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
37. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood
38. Sterols and isoprenoids: Signaling molecules derived from the cholesterol biosynthetic pathway
39. Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of mature sterol regulatory element-binding protein
40. Bridging the gap: Composition, regulation, and physiological function of the IkappaB kinase complex
41. Rel/NF-kappa B/I kappa B story
42. NF-kappa B: Ten years after
43. Is NF-kappaB the sensor of oxidative stress?
44. How NF-kappaB is activated: The role of the IkappaB kinase (IKK) complex
45. Activators and target genes of Rel/NF-kappaB transcription factors
46. Activation of NF-kappaB by antineoplastic agents. Role of protein kinase C
47. Daunorubicin activates NFkappaB and induces kappaB-dependent gene expression in HL-60 promyelocytic and Jurkat T lymphoma cells
48. p53, the cellular gatekeeper for growth and division
49. p53 in tumor progression: Life, death, and everything
50. Cell cycle regulation and apoptosis
51. The p53 network
52. NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress
53. Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment
54. NF-kappa B-dependent Fas ligand expression
55. Up-regulation of the multidrug resistance genes, mrp1 and mdr1b, and down-regulation of the organic anion transporter, mrp2, and the bile salt transporter, spgp, in endotoxemic rat liver
56. Regulation of hepatic transport systems in rat liver after partial hepatectomy
57. Overexpression of mdr2 gene by peroxisome proliferators in the mouse liver
58. Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse
59. Regulation of mdr2 P-glycoprotein expression by bile salts
60. Regulation of the Mdr2 P-glycoprotein expression by bile salts in rats and in primary cultures of rat hepatocytes
61. Enhancement of mdr2 gene transcription mediates the biliary transfer of phosphatidylcholine supplied by an increased biosynthesis in the pravastatin-treated rat
62. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) induce hepatic expression of the phospholipid translocase mdr2 in rats
63. Signal transduction from the endoplasmic reticulum to the cell nucleus
64. Characterization of the rat mdr2 promoter and its regulation by the transcription factor Sp1
65. Induction of hepatic Mdr2 expression by cholesterol synthesis inhibitors (statins) is mediated via Srebps
66. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver
67. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis
68. Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1/P-glycoprotein
69. Molecular cloning and characterization of the murine bile salt export pump
70. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat
71. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors
72. Molecular pathogenesis of cholestasis
73. Differential expression of basolateral and canalicular organic anion transporters during regeneration of rat liver
74. Induction of cMrp/cMoat gene expression by cisplatin, 2-acetylaminofluorene, or cycloheximide in rat hepatocytes
75. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells
76. The human multidrug resistance protein 2 gene: Functional characterization of the 5'-flanking region and expression in hepatic cells
77. Sequence analysis and functional characterization of the 5'-flanking region of the rat multidrug resistance protein 2 (mrp2) gene
78. Characterization of the 5'-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison with the multidrug resistance protein 3 (MRP3) gene
79. Interleukin-1β suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation
80. Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP
81. Conjugate export pumps of the multidrug resistance protein (MRP) family: Localization, substrate specificity, and MRP2-mediated drug resistance
82. Glutathione S-conjugate transport in hepatocytes entering the cell cycle is preserved by a switch in expression from the apical MRP2 to the basolateral MRPI transporting protein
83. Increased level of the multidrug resistance protein in lateral membranes of proliferating hepatocyte-derived cells
84. Expression of multidrug resistance Protein/GS-X pump and gamma-glutamylcysteine synthetase genes is regulated by oxidative stress
85. Frequent coexpression of MRP/GS-X pump and gamma- glutamylcysteine synthetase mRNA in drug-resistant cells, untreated tumor cells, and normal mouse tissues
86. Cloning and sequence analysis of the promoter region of the MRP gene of HL60 cells isolated for resistance to adriamycin
87. Evidence that SP1 modulates transcriptional activity of the multidrug resistance-associated protein gene
88. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53
89. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma
90. Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells
91. Characterization of the inducible nature of MRP3 in rat liver
92. ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3)
93. cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3)
94. Hepatic expression of multidrug resistance-associated protein- like proteins maintained in eisai hyperbilirubinemic rats
95. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane
96. Human MRP3 transporter: Identification of the 5'-flanking region, genomic organization and alternative splice variants
97. Transcriptional activation of the MDR1 gene by UV irradiation. Role of NF-Y and Sp1
98. Regulation and function of the multidrug resistance genes in liver
99. Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light
100. Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene
101. Context-dependent transcriptional regulation
102. Sp1 and egr-1 have opposing effects on the regulation of the rat Pgp2/mdr1b gene
103. p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents
104. Wild-type p53-mediated induction of rat mdr1b expression by the anticancer drug daunorubicin
105. Expression of multidrug resistance genes in rat liver during regeneration and after carbon tetrachloride intoxication
106. NF-KB-mediated induction of mdr1b expression by insulin in rat hepatoma cells
107. Up-regulation of multidrug resistance P-glycoprotein via nuclear factor-kappaB activation protects kidney proximal tubule cells from cadmium- and reactive oxygen species-induced apoptosis
108. TNFα-mediated up-regulation of the multidrug resistance gene Mdr1b but not of Mrp1 in rat hepatocytes is dependent on NF-κB activation
109. P-glycoprotein: A major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans
110. Altered expression of hepatic cytochromes P-450 in mice deficient in one or more mdr1 genes
111. Disruption of the mouse mdr1a p-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
112. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
113. Orphan nuclear receptors - New ligands and new possibilities
114. A unified nomenclature system for the nuclear receptor superfamily
115. Identification and characterization of a putative bile acid-responsive element in cholesterol 7 alpha-hydroxylase gene promoter
116. Molecular mechanisms of cytochrome P-450 induction by xenobiotics: An expanded role for nuclear hormone receptors
117. Transcriptional activation of the cholesterol 7alpha-hydroxylase gene (CYP7A) by nuclear hormone receptors
118. HNF4 and COUP-TFII interact to modulate transcription of the cholesterol 7alpha-hydroxylase gene (CYP7A1)
119. Structure of the RXR-RAR DNA-binding complex on the retinoic acid response element DR1
120. Characterization of the basal and carcinogen regulatory elements of the rat mdr1b promoter
121. Cloning and regulation of the rat mdr2 gene
122. Sterol regulatory element binding protein binds to a cis element in the promoter of the farnesyl diphosphate synthase gene
123. The DNA-binding specificity of the hepatocyte nuclear factor 3/forkhead domain is influenced by amino-acid residues adjacent to the recognition helix
124. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis
125. Up-regulation of multidrug resistance-associated protein 2 (MRP2) expression in rat hepatocytes by dexamethasone
126. The ABCA subclass of mammalian transporters
127. ABCG1 (ABC8), the human homolog of the drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport
128. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells
129. Transport function and hepatocellular localization of mrp6 in rat liver
130. Oxysterols: Modulators of cholesterol metabolism and other processes
131. Nuclear orphan receptors control cholesterol catabolism
132. Seeking ligands for lonely orphan receptors
133. Biochemical pathways of caspase activation during apoptosis
134. Mechanisms of hepatic toxicity. I. TNF-induced liver injury
135. Tumor necrosis factor receptor and Fas signaling mechanisms
136. Molecular regulation of hepatocellular transport systems in cholestasis
137. Physiological and pathophysiological regulation of cytochrome P450
138. Characterization of the promoter region of the human MDR3 p-glycoprotein gene